The upfront and near-term payment, backed by milestones that could take the total value of the licensing deal to around ... scalability," he said. Novo Nordisk and Septerna will jointly carry ...

Novo Nordisk announces a $2.2 billion deal with Septerna to tap the growing obesity treatment market. SEPN is entitled to receive around $2.2 billion from NVO under the new collaboration deal ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

When the proposed three-way deal was first announced earlier this year, it prompted debate about the antitrust implications in part because Catalent is working with many of Novo Nordisk's ...

Novo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its bumper weight ...

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha. Skip to content Home page Seeking Alpha - Power to Investors About Premium Explore Alpha Picks Home ...